147 related articles for article (PubMed ID: 27587310)
1. Safety and Efficacy of Transplantation with Allogeneic Skin Tumors to Treat Chemically-Induced Skin Tumors in Mice.
Zhang Z; Sun H; Zhang J; Ge C; Dong S; Li Z; Li R; Chen X; Li M; Chen Y; Zou Y; Qian Z; Yang L; Yang J; Zhu Z; Liu Z; Song X
Med Sci Monit; 2016 Sep; 22():3113-23. PubMed ID: 27587310
[TBL] [Abstract][Full Text] [Related]
2. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
[TBL] [Abstract][Full Text] [Related]
3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
4. Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.
Anderson LD; Mori S; Mann S; Savary CA; Mullen CA
Cancer Res; 2000 Oct; 60(20):5797-802. PubMed ID: 11059776
[TBL] [Abstract][Full Text] [Related]
5. Attribution of NKG2DL to the inhibition of early stage allogeneic tumors in mice.
Hua L; Fang M; Dong B; Guo S; Cui C; Liu J; Yao Y; Xiao Y; Li X; Ren Y; Meng X; Hao X; Zhao P; Song Y; Wang L; Yu Y
Oncotarget; 2016 Dec; 7(50):82369-82383. PubMed ID: 27448968
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine.
Anderson LD; Petropoulos D; Everse LA; Mullen CA
Cancer Res; 1999 Apr; 59(7):1525-30. PubMed ID: 10197624
[TBL] [Abstract][Full Text] [Related]
7. Cellular tumor vaccines administered after T cell-depleted allogeneic bone marrow transplantation induce effective anti-tumor immune responses.
Mundhada S; Shaw J; Mori S; Savary CA; Mullen CA
Leuk Lymphoma; 2005 Apr; 46(4):571-80. PubMed ID: 16019486
[TBL] [Abstract][Full Text] [Related]
8. [Immunomodulatory effects of human placental-derived mesenchymal stem cells on immune rejection in mouse allogeneic skin transplantation].
Wang Q; Liu T; Zhang Y; Chen D; Wang L; Li Y; Wei J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jul; 27(7):775-80. PubMed ID: 24063162
[TBL] [Abstract][Full Text] [Related]
9. [Effect of age on cell-mediated immune response to allogeneic tumor graft in ICR-JCL mice (author's transl)].
Chiba T
Nihon Hifuka Gakkai Zasshi; 1979 Oct; 89(11):745-59. PubMed ID: 316029
[No Abstract] [Full Text] [Related]
10. Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease.
Ohashi M; Kobayashi A; Hara H; Miura Y; Yoshida K; Kushida M; Ikarashi Y; Mandai M; Kitajima M; Yoshida T; Aoki K
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2208-15. PubMed ID: 16609036
[TBL] [Abstract][Full Text] [Related]
11. Differential requirement for a cellular type-1 immune response in tumor-associated versus alloantigen-targeted GvT effects.
Stelljes M; Specht C; Albring J; Volkmann S; Schlösser V; Pauels HG; Poremba C; Bisping G; Opitz C; Scheffold C; Silling G; Kiehl M; Berdel WE; Kienast J
Transplantation; 2007 Feb; 83(3):314-22. PubMed ID: 17297406
[TBL] [Abstract][Full Text] [Related]
12. Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors.
Demirer T; Barkholt L; Blaise D; Pedrazzoli P; Aglietta M; Carella AM; Bay JO; Arpaci F; Rosti G; Gurman G; Niederwieser D; Bregni M;
Nat Clin Pract Oncol; 2008 May; 5(5):256-67. PubMed ID: 18398414
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic immunotherapy to optimize the graft-versus-tumor effect: concepts and controversies.
Porter DL
Hematology Am Soc Hematol Educ Program; 2011; 2011():292-8. PubMed ID: 22160048
[TBL] [Abstract][Full Text] [Related]
14. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
Tam YK; Klingemann HG
Biol Blood Marrow Transplant; 1999; 5(3):144-54. PubMed ID: 10392960
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo characterization of graft-versus-tumor responses in melanoma patients after allogeneic peripheral blood stem cell transplantation.
Kurokawa T; Fischer K; Bertz H; Hoegerle S; Finke J; Mackensen A
Int J Cancer; 2002 Sep; 101(1):52-60. PubMed ID: 12209588
[TBL] [Abstract][Full Text] [Related]
16. Multidonor bone marrow transplantation improves donor engraftment and increases the graft versus tumor effect while decreasing graft-versus-host disease.
Zhanna Y; Ester H; Lola W; Offer G; Shimon S; Shapira MY
Transpl Int; 2011 Feb; 24(2):194-200. PubMed ID: 20854413
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthesis contributes to inhibition of graft-versus-tumor-effects against intraperitoneal Meth A tumor.
Song EK; Lee NR; Sohn MH; Kwak JY; Yim CY
Cell Immunol; 2004 Aug; 230(2):109-18. PubMed ID: 15598426
[TBL] [Abstract][Full Text] [Related]
18. Reconstructing immunity after allogeneic transplantation.
Giver CR; Li JM; Hossain MS; Lonial S; Waller EK
Immunol Res; 2004; 29(1-3):269-82. PubMed ID: 15181288
[TBL] [Abstract][Full Text] [Related]
19. A TLR5 agonist enhances CD8(+) T cell-mediated graft-versus-tumor effect without exacerbating graft-versus-host disease.
Ding X; Bian G; Leigh ND; Qiu J; McCarthy PL; Liu H; Aygun-Sunar S; Burdelya LG; Gudkov AV; Cao X
J Immunol; 2012 Nov; 189(10):4719-27. PubMed ID: 23045613
[TBL] [Abstract][Full Text] [Related]
20. TRAIL-induced cell death cooperates with IFN-gamma activation in the graft-versus-tumor effect against colon tumors.
Tateishi K; Ohta M; Guleng B; Kanai F; Tanaka Y; Asaoka Y; Jazag A; Imamura J; Imamura T; Ijichi H; Ikenoue T; Kawakami T; Fukushima Y; Washida M; Sata M; Miyagishi M; Taira K; Yoshida H; Kawabe T; Omata M
Int J Cancer; 2006 May; 118(9):2237-46. PubMed ID: 16331624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
